A stem cell medium containing neural stimulating factor induces a pancreatic cancer stem-like cell-enriched population

International Journal of Oncology

Volumn 45, Issue 5, 2014, Pages 1857-1866

  Watanabe, Yusaku ^a   Yoshimura, Kiyoshi ^a   Yoshikawa, Koichi ^a   Tsunedomi, Ryoichi ^a   Shindo, Yoshitaro ^a   Matsukuma, Sou ^a   Maeda, Noriko ^a   Kanekiyo, Shinsuke ^a   Suzuki, Nobuaki ^a   Kuramasu, Atsuo ^a   Sonoda, Kouhei ^a   Tamada, Koji ^a   Kobayashi, Sei ^a   Saya, Hideyuki ^b   Hazama, Shoichi ^a   Oka, Masaki ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Cancer stem cells; Cell culture method; Pancreatic cancer

Indexed keywords

ACETYLCYSTEINE; ALDEHYDE DEHYDROGENASE; CD24 ANTIGEN; CD44V ANTIGEN; CDH 2 PROTEIN; CELL PROTEIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FN 1 PROTEIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; HERMES ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 5; INTERLEUKIN 9; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; NEURAL CELL SURVIVOR FACTOR 1; PLATELET DERIVED GROWTH FACTOR BB; RANTES; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR ZEB1; TRANSCRIPTION FACTOR ZEB2; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG; VIM PROTEIN; CULTURE MEDIUM; SIGNAL PEPTIDE;

ANTIGEN EXPRESSION; ARTICLE; CANCER STEM CELL; CARCINOGENICITY; CELL CYCLE; CELL CYCLE G1 PHASE; CELL POPULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PANCREAS CANCER; PANCREATIC CANCER CELL LINE; STEM CELL CULTURE; SUSPENSION CELL CULTURE; CHEMISTRY; CULTURE MEDIUM; DRUG EFFECTS; EPITHELIAL MESENCHYMAL TRANSITION; FLOW CYTOMETRY; GENETICS; METABOLISM; NEURAL STEM CELL; PANCREATIC NEOPLASMS; PATHOLOGY; PHARMACOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CULTURE MEDIA; EPITHELIAL-MESENCHYMAL TRANSITION; FLOW CYTOMETRY; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASTIC STEM CELLS; NEURAL STEM CELLS; PANCREATIC NEOPLASMS;

EID: 84907210903     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2603     Document Type: Article

References (35)

1. Reya T, Morrison SJ, Clarke MF and Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 414: 105-111, 2001.
2. Visvader JE and Lindeman GJ: Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768, 2008.
3. Costello RT, Mallet F, Gaugler B, et al: Human acute myeloid leukemia CD34+/CD38-progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities. Cancer Res 60: 4403-4411, 2000.
4. Dean M, Fojo T and Bates S: Tumour stem cells and drug resistance. Nat Rev Cancer 5: 275-284, 2005.
5. Guzman ML, Swiderski CF, Howard DS, et al: Preferential induction of apoptosis for primary human leukemic stem cells. Proc Natl Acad Sci USA 99: 16220-16225, 2002.
6. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62: 10-29, 2012.
7. Li C, Heidt DG, Dalerba P, et al: Identification of pancreatic cancer stem cells. Cancer Res 67: 1030-1037, 2007.
8. Hermann PC, Huber SL, Herrler T, et al: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1: 313-323, 2007.
9. Eramo A, Lotti F, Sette G, et al: Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15: 504-514, 2008.
10. K ondo T, Setoguchi T and Taga T: Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 101: 781-786, 2004.
11. Wu C and Alman BA: Side population cells in human cancers. Cancer Lett 268: 1-9, 2008.
12. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al: Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115, 2007.
13. Dontu G, Abdallah WM, Foley JM, et al: In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17: 1253-1270, 2003.
14. Yamamoto K, Yahara N, Gondo T, Ishihara T and Oka M: Establishment and characterization of a new human pancreatic cancer cell line, YPK-1. Bull Yamaguchi Med Sch 49: 33-42, 2002.
15. Tsunedomi R, Iizuka N, Tamesa T, et al: Decreased ID2 promotes metastatic potentials of hepatocellular carcinoma by altering secretion of vascular endothelial growth factor. Clin Cancer Res 14: 1025-1031, 2008.
16. Tsunedomi R, Iizuka N, Harada S and Oka M: Susceptibility of hepatoma-derived cells to histone deacetylase inhibitors is associated with ID2 expression. Int J Oncol 42: 1159-1166, 2013.
17. Nagano O, Okazaki S and Saya H: Redox regulation in stem-like cancer cells by CD44 variant isoforms. Oncogene 32: 5191-5198, 2013.
18. Tanabe KK, Ellis LM and Saya H: Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 341: 725-726, 1993.
19. Abdullah LN and Chow EK: Mechanisms of chemoresistance in cancer stem cells. Clin Transl Med 2: 3, 2013.
20. Dick JE: Stem cell concepts renew cancer research. Blood 112: 4793-4807, 2008.
21. Thiery JP, Acloque H, Huang RY and Nieto MA: Epithelialmesenchymal transitions in development and disease. Cell 139: 871-890, 2009.
22. Prat A, Parker JS, Karginova O, et al: Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12: R68, 2010.
23. Polyak K and Weinberg RA: Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-273, 2009.
24. M ani SA, Guo W, Liao MJ, et al: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715, 2008.
25. M orel AP, Lievre M, Thomas C, Hinkal G, Ansieau s and Puisieux A: Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 3: E2888, 2008.
26. M or G, Yin G, Chefetz I, Yang Y and Alvero A: Ovarian cancer stem cells and inflammation. Cancer Biol Ther 11: 708-713, 2011.
27. Chiou SH, Yu CC, Huang CY, et al: Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 14: 4085-4095, 2008.
28. Lee J, Kotliarova S, Kotliarov Y, et al: Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9: 391-403, 2006.
29. Hueng DY, Sytwu HK, Huang SM, Chang C and Ma HI: Isolation and characterization of tumor stem-like cells from human meningiomas. J Neurooncol 104: 45-53, 2011.
30. Z hong Y, Guan K, Guo S, et al: Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells. Cancer Lett 299: 150-160, 2010.
31. Pollard SM, Yoshikawa K, Clarke ID, et al: Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 4: 568-580, 2009.
32. Z iober AF, Falls EM and Ziober BL: The extracellular matrix in oral squamous cell carcinoma: Friend or foe? Head Neck 28: 740-749, 2006.
33. Timpl R, Rohde H, Robey PG, Rennard SI, Foidart JM and Martin GR: Laminin -A glycoprotein from basement membranes. J Biol Chem 254: 9933-9937, 1979.
34. Calabrese C, Poppleton H, Kocak M, et al: A perivascular niche for brain tumor stem cells. Cancer Cell 11: 69-82, 2007.
35. Takeishi S, Matsumoto A, Onoyama I, Naka K, Hirao A and Nakayama KI: Ablation of Fbxw7 eliminates leukemia-initiating cells by preventing quiescence. Cancer Cell 23: 347-361, 2013.